INTRACALVARIAL DRUG DELIVERY STRATEGIES INTO SKULL BONE MARROW TO CREATE AN ANTITUMORAL MYELOID CELL IMMUNE RESPONSE TO GLIOBLASTOMA

Regents Of The University Of California, San Francisco, The

Investigators